Addpharma Inc. (South Korea)

Addpharma is a South Korean pharmaceutical company that carries out the entire drug development process, from planning to approval. Its official website describes integrated, data-driven design from planning to licensing, parallel development of formulation, analysis, stability testing and clinical preparation, and clinical design through product approval. The company reports cumulative product approvals of 127 since its first approval in 2019, 12 Phase 3 projects, and first place in domestic IND approvals in 2024. It is also a testing and analysis institution designated by the Ministry of Food and Drug Safety, providing testing of raw and finished pharmaceuticals and analytical method validation.

Addpharma's official website states that it carries out the entire drug development process from planning to approval. The company reports cumulative product approvals of 127 since its first approval in 2019, and 12 Phase 3 projects. In 2024 it ranked first in domestic IND approvals. It is also a testing and analysis institution designated by the Ministry of Food and Drug Safety, providing testing of raw and finished pharmaceuticals and analytical method validation.

A company that carries out the entire drug development process and sets the standard for drug development.

1. 1애드파마 ADDPHARMA — 의약품 연구개발·시험검사addpharma.co.kr
2. 2회사소개 — 애드파마 ADDPHARMAaddpharma.co.kr